CENPF Antikörper (AA 1759-2093)
Kurzübersicht für CENPF Antikörper (AA 1759-2093) (ABIN7464494)
Target
Alle CENPF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1759-2093
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Protein G purified
-
Immunogen
- Protein fragment expressed in E. coli corresponding to amino acids 1759-2093.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- WB: 1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Kommentare
-
Positive Control: HeLa (G2 phase)
Validation: Orthogonal
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, No Preservative
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- CENPF (Centromere Protein F (CENPF))
-
Andere Bezeichnung
- centromere protein F
-
Hintergrund
- Centromere protein F , CENF , CILD31 , PRO1779 , STROMS , hcp-1,This gene encodes a protein that associates with the centromere-kinetochore complex. The protein is a component of the nuclear matrix during the G2 phase of interphase. In late G2 the protein associates with the kinetochore and maintains this association through early anaphase. It localizes to the spindle midzone and the intracellular bridge in late anaphase and telophase, respectively, and is thought to be subsequently degraded. The localization of this protein suggests that it may play a role in chromosome segregation during mitotis. It is thought to form either a homodimer or heterodimer. Autoantibodies against this protein have been found in patients with cancer or graft versus host disease. [provided by RefSeq, Jul 2008]
-
Molekulargewicht
- 358 kDa
-
Gen-ID
- 1063
-
UniProt
- P49454
-
Pathways
- Chromatin Binding, M Phase, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-